Last updated date
ABOUT THIS STUDY
Assessment of duration of action, safety & toleration of different formulations and doses of UK-369,003 and Cialis in patients with male erectile dysfunction. Patients should have previously been on PDE5 inhibitors and have been respondents to the drug. Duration of treatment is 4 weeks.
- Erectile Dysfunction
- Alpha blockers and Nitrates of any preparation
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
ImpotenceEffect of Sildenafil on Endothelial Function
ImpotenceEvaluation of the Index of Sexual Life Questionnaire
- La Rochelle,
- Lyon Cedex 03,
- PARIS Cedex 13,
ImpotenceAssessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction
ImpotenceA Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses
- Belfast, Northern Ireland